In-Vitro Diagnostics Market Updates

Skyquest Technology's expert advisors continuously track and analyze the latest developments and updates related to in-vitro diagnostics market. Our team of analysts stay abreast of all the recent news stories shaping the industry including new product launches by major companies, strategic partnerships, M&As, Patent filings and industry and regulatory developments.

In-Vitro Diagnostics Market News

in In-Vitro Diagnostics Market
  • In June 2025, Revvity, Inc. introduced three new Mimix reference standards specifically designed for in-vitro diagnostic (IVD) applications. These standards are engineered to support next-generation sequencing (NGS) and droplet digital PCR (ddPCR) assays targeting somatic mutations in human genomic DNA. Developed under U.S. FDA regulatory guidelines, these standards enable laboratories to enhance workflow integration, improve test performance monitoring, and minimize assay variability and systemic errors. 
  • In April 2025, Roche, a medical device company, announced the launch of Chest Pain Triage algorithm, in collaboration with Universitätsklinikum Heidelberg. This is a CE-marked IVD medical device which is used to transform cardiac care.
  • In March 2025, Thermo Fisher Scientific announced the launch the Applied Biosystems SeqStudio Flex Dx Genetic Analyzer, which is designed to address the evolving needs of clinical laboratories. This IVDR-compliant capillary electrophoresis (CE) system is engineered for regulatory compliance, operational efficiency, user-friendly workflows, and flexible run scheduling. The SeqStudio Flex Dx supports both clinical diagnostics and research applications, enabling Sanger sequencing and fragment analysis for targeted genomic testing.
  • In January 2025, ️Argonaut Manufacturing Services expanded its partnership with Akoya Biosciences Inc., becoming the manufacturing partner for Akoya's IVD assays under development. This strengthened collaboration highlights Argonaut's growing role in supporting both early-stage and established diagnostic product lines, further advancing precision medicine by ensuring high-quality and scalable diagnostic manufacturing capabilities.

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Global In-Vitro Diagnostics Market size was valued at USD 99.6 billion in 2023 and is poised to grow from USD 105.68 billion in 2024 to USD 169.71 billion by 2032, growing at a CAGR of 6.1% during the forecast period (2025-2032).

F. Hoffmann-La Roche Ltd, Hologic Inc, Abbott Laboratories, Siemens AG, Exact Sciences Corp, bioMerieux SA, Quidelortho Corp, Sysmex Corp, Bio-Rad Laboratories Inc, Thermo Fisher Scientific Inc, Becton Dickinson, Danaher Corporation, Illumina, DiaSorin (Luminex Corporation), Koninklijke Philips NV (Philips) - Philips healthcare, Qiagen N.V., Agilent Technologies Inc, Bruker Corporation, Quest Diagnostics, Revvity Inc

The increase in prevalence of chronic disease and surge in need for early diagnosis drive the growth of the market. According to Center for Disease control and prevention, it was reported that around 60% of American have at least one chronic disease, and nearly 40% have two or more chronic disease.

Rising awareness about early disease detection and the need for faster, more accurate diagnostic tests will drive market growth. The increasing adoption of point-of-care testing and portable diagnostic devices is expected to enhance accessibility and patient outcomes.

The Asia-Pacific in-vitro diagnostics market share is driven by a geriatric population, increase in prevalence of chronic diseases and rise in demand for early diagnostics. Government initiatives across the region promote healthcare infrastructure and accessibility. Expansion of local operations by major players improves market reach, customer support, and availability of advanced diagnostic solutions.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global In-Vitro Diagnostics Market
In-Vitro Diagnostics Market

Report ID: SQMIG35A3049

[email protected]
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE